CVE:FIRESupreme Cannabis Stock Price, Forecast & News Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Supreme Cannabis Company Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Compare Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume5.24 million shsAverage Volume1.17 million shsMarket CapitalizationC$655.28 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsHeadlinesSocial Media The Supreme Cannabis Company, Inc. engages in the production of medical cannabis in Canada. The company was formerly known as Supreme Pharmaceuticals Inc. and changed its name to The Supreme Cannabis Company, Inc. in December 2017. The Supreme Cannabis Company, Inc. was incorporated in 1979 and is headquartered in Toronto, Canada.Read More Beat the Market (BTM) Rank™ 3.3 Analyst's Opinion Consensus RatingSupreme Cannabis has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of C$0.63, Supreme Cannabis has a potential upside of ∞ from its current price of C$0.00.Amount of Analyst CoverageSupreme Cannabis has received no research coverage in the past 90 days. Previous Next 2.8 Community Rank Outperform VotesSupreme Cannabis has received 227 “outperform” votes. (Add your “outperform” vote.)Underperform VotesSupreme Cannabis has received 172 “underperform” votes. (Add your “underperform” vote.)Community SentimentSupreme Cannabis has received 56.89% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Supreme Cannabis and other stocks. Vote “Outperform” if you believe FIRE will outperform the S&P 500 over the long term. Vote “Underperform” if you believe FIRE will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldSupreme Cannabis does not currently pay a dividend.Dividend GrowthSupreme Cannabis does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Supreme Cannabis insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Supreme Cannabis are expected to decrease by -100.00% in the coming year, from C$0.09 to C$0.00 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Supreme Cannabis is -51.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Supreme Cannabis is -51.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next Analyst Opinion: 3.3Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.21 out of 5 stars Industry, Sector and Symbol Stock Exchange CVE Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolCVE:FIRE Previous Symbol CUSIPN/A CIKN/A Webwww.supreme.ca Phone+1-416-6307272Debt Debt-to-Equity Ratio21.04 Current Ratio2.28 Quick Ratio1.76Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesC$12.43 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow20.55 Book ValueC$0.57 per share Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares289,947,008Market CapC$655.28 million Next Earnings DateN/A OptionableNot Optionable Receive FIRE News and Ratings via Email Sign-up to receive the latest news and ratings for FIRE and its competitors with MarketBeat's FREE daily newsletter. Supreme Cannabis (CVE:FIRE) Frequently Asked Questions Do Wall Street analysts recommend investors buy shares of Supreme Cannabis? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Supreme Cannabis in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Supreme Cannabis. What price target have analysts set for FIRE? 2 equities research analysts have issued 12 month target prices for Supreme Cannabis' shares. Their forecasts range from C$0.35 to C$0.90. On average, they anticipate Supreme Cannabis' stock price to reach C$0.63 in the next year. View analysts' price targets for Supreme Cannabis. Has Supreme Cannabis been receiving favorable news coverage? Media coverage about FIRE stock has trended somewhat positive on Saturday, according to InfoTrie. InfoTrie identifies positive and negative media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Supreme Cannabis earned a media sentiment score of 2.0 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the next few days. View the latest news aboutSupreme Cannabis. Who are some of Supreme Cannabis' key competitors? Some companies that are related to Supreme Cannabis include Aurora Cannabis (ACB), Aphria (APHA), Knight Therapeutics (GUD), Ecofibre (EOF), HLS Therapeutics (HLS), OrganiGram (OGI), Hexo (HEXO), HEXO (HEXO), Next Science (NXS), ICC Labs (ICC), Amryt Pharma (AMYT), Benchmark (BMK), ESSA Pharma (EPI), Probiotec (PBP) and Green Organic Dutchman (TGOD). View all competitors. What other stocks do shareholders of Supreme Cannabis own? Based on aggregate information from My MarketBeat watchlists, some companies that other Supreme Cannabis investors own include Aurora Cannabis (ACB), Canopy Growth (WEED), Aphria (APHA), OrganiGram (OGI), 1933 Industries (TGIF), Green Organic Dutchman (TGOD), Advanced Micro Devices (AMD), Aphria (APHA), Hydropothecary (THCX) and MedReleaf (LEAF). Who are Supreme Cannabis' key executives? Supreme Cannabis' management team includes the following people: Mr. Navdeep Dhaliwal, CEO & DirectorMr. John Alexander Fowler, Pres, Founder & DirectorMr. Dimitre Naoumov, Chief Financial OfficerMr. Sunpreet Gokhale, Gen. CounselMr. Scott Robertson Walters, VP of Corp. Devel. & Director What is Supreme Cannabis' stock symbol? Supreme Cannabis trades on the Canadian Venture Exchange (CVE) under the ticker symbol "FIRE." How big of a company is Supreme Cannabis? Supreme Cannabis has a market capitalization of C$0.00 and generates C$12.43 million in revenue each year. What is Supreme Cannabis' official website? The official website for Supreme Cannabis is www.supreme.ca. How can I contact Supreme Cannabis? Supreme Cannabis' mailing address is 371 Jones Ave, TORONTO, ON M4J 3G5, Canada. The company can be reached via phone at +1-416-6307272. This page was last updated on 6/6/2020 by MarketBeat.com Staff
